John Schwarz
Known title: DirectorCIK: 0001184223
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Synopsys Launches $1B Buyback and AI Chip Libraries. Synopsys announced a $1 billion accelerated share buyback, signaling management confidence in the company's value. The firm also introduced AI chipmaking libraries to support semiconductor workflows, aligning with broader industry trends in AI-defined manufacturing. Analysts have responded by raising price targets, with the current average sitting well above the stock's 52-week low.
Transaction History
| TDC | ▲ Buy | Grant | 8,790 | $0 | 5/14/2026 | View on chart |
| SNPS | ▲ Buy | Grant | 453 | $0 | 4/16/2026 | View on chart |
| TDC | ▲ Buy | Grant | 11,489 | $0 | 5/15/2025 | View on chart |
| SNPS | ▲ Buy | Grant | 491 | $0 | 4/10/2025 | View on chart |
| TDC | ▲ Buy | Grant | 6,927 | $0 | 5/14/2024 | View on chart |
| SNPS | ▲ Buy | Grant | 356 | $0 | 4/10/2024 | View on chart |
| TDC | ▲ Buy | Grant | 6,176 | $0 | 5/12/2023 | View on chart |
| SNPS | ▲ Buy | Grant | 464 | $0 | 4/12/2023 | View on chart |
| TDC | ▲ Buy | Grant | 5,828 | $0 | 5/10/2022 | View on chart |
| SNPS | ▲ Buy | Grant | 563 | $0 | 4/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Teradata Reports New Enterprise AI Deals in Healthcare
Teradata announced new enterprise AI customer engagements in the healthcare and life sciences sectors. This development highlights the company's continued focus on artificial intelligence applications within specialized industries. The news coincides with a period of strong performance for several technology peers, including Palantir and Snowflake, suggesting a broader positive sentiment in the sector.
Teradata Reports New Enterprise AI Deals in Healthcare. Teradata announced new enterprise AI customer engagements in the healthcare and life sciences sectors. This development highlights the company's continued focus on artificial intelligence applications within specialized industries. The news coincides with a period of strong performance for several technology peers, including Palantir and Snowflake, suggesting a broader positive sentiment in the sector.